Michael H. Davidson to Anti-Obesity Agents
This is a "connection" page, showing publications Michael H. Davidson has written about Anti-Obesity Agents.
Connection Strength
0.635
-
Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index =27 kg/m(2). Am J Cardiol. 2013 Apr 15; 111(8):1131-8.
Score: 0.451
-
Efficacy of antiobesity therapies. Am J Clin Nutr. 2000 Mar; 71(3):844.
Score: 0.184